Health technology assessment of biosimilars worldwide: a scoping review (2020)
Ascef, Bruna de Oliveira; Lopes, Ana Carolina de Freitas; Soarez, Patricia Coelho De 
Source: Health research policy and systems. Unidade: FM
Subjects: TECNOLOGIAS DA SAÚDE, POLÍTICA DE SAÚDE, BIOMEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASCEF, Bruna de Oliveira e LOPES, Ana Carolina de Freitas e SOAREZ, Patricia Coelho De. Health technology assessment of biosimilars worldwide: a scoping review. Health research policy and systems, v. 18, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12961-020-00611-y. Acesso em: 16 out. 2024.APA
Ascef, B. de O., Lopes, A. C. de F., & Soarez, P. C. D. (2020). Health technology assessment of biosimilars worldwide: a scoping review. Health research policy and systems, 18( 1). doi:10.1186/s12961-020-00611-yNLM
Ascef B de O, Lopes AC de F, Soarez PCD. Health technology assessment of biosimilars worldwide: a scoping review [Internet]. Health research policy and systems. 2020 ; 18( 1):[citado 2024 out. 16 ] Available from: https://doi.org/10.1186/s12961-020-00611-yVancouver
Ascef B de O, Lopes AC de F, Soarez PCD. Health technology assessment of biosimilars worldwide: a scoping review [Internet]. Health research policy and systems. 2020 ; 18( 1):[citado 2024 out. 16 ] Available from: https://doi.org/10.1186/s12961-020-00611-y
